1
|
Jemal A, Siegel R, Ward E, et al: Cancer
statistics, 2006. CA Cancer J Clin. 56:106–130. 2006. View Article : Google Scholar : PubMed/NCBI
|
2
|
Wolfgang CL, Herman JM, Laheru DA, et al:
Recent progress in pancreatic cancer. CA Cancer J Clin. 63:318–348.
2013. View Article : Google Scholar : PubMed/NCBI
|
3
|
LeCouter J, Kowalski J, Foster J, et al:
Identification of an angiogenic mitogen selective for endocrine
gland endothelium. Nature. 412:877–884. 2001. View Article : Google Scholar : PubMed/NCBI
|
4
|
Monnier J and Samson M: Cytokine
properties of prokineticins. FEBS J. 275:4014–4021. 2008.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Ren LN, Li QF, Xiao FJ, et al: Endocrine
glands-derived vascular endothelial growth factor protects
pancreatic cancer cells from apoptosis via upregulation of the
myeloid cell leukemia-1 protein. Biochem Biophys Res Commun.
386:35–39. 2009. View Article : Google Scholar : PubMed/NCBI
|
6
|
Bosman FT: WHO Classification of Tumours
of the Digestive System. 4th. IARC Press; Lyon: 2010
|
7
|
Song JW and Lee JH: New morphological
features for grading pancreatic ductal adenocarcinomas. Biomed Res
Int. 2013:1752712013. View Article : Google Scholar : PubMed/NCBI
|
8
|
Nagano H, Goi T, Koneri K, et al:
Endocrine gland-derived vascular endothelial growth factor
(EG-VEGF) expression in colorectal cancer. J Surg Oncol.
96:605–610. 2007. View Article : Google Scholar : PubMed/NCBI
|
9
|
LeCouter J, Lin R, Tejada M, et al: The
endocrine-gland-derived VEGF homologue Bv8 promotes angiogenesis in
the testis: Localization of Bv8 receptors to endothelial cells.
Proc Natl Acad Sci USA. 100:2685–2690. 2003. View Article : Google Scholar : PubMed/NCBI
|
10
|
Kisliouk T, Levy N, Hurwitz A and Meidan
R: Presence and regulation of endocrine gland vascular endothelial
growth factor/prokineticin-1 and its receptors in ovarian cells. J
Clin Endocrinol Metab. 88:3700–3707. 2003. View Article : Google Scholar : PubMed/NCBI
|
11
|
Morales A, Vilchis F, Chávez B, et al:
Expression and localization of endocrine gland-derived vascular
endothelial growth factor (EG-VEGF) in human pancreas and
pancreatic adenocarcinoma. J Steroid Biochem Mol Biol. 107:37–41.
2007. View Article : Google Scholar : PubMed/NCBI
|
12
|
Rini BI: Vascular endothelial growth
factor-targeted therapy in metastatic renal cell carcinoma. Cancer.
115:2306–2312. 2009. View Article : Google Scholar : PubMed/NCBI
|
13
|
Jiang X, Abiatari I, Kong B, et al:
Pancreatic islet and stellate cells are the main sources of
endocrine gland-derived vascular endothelial growth
factor/prokineticin-1 in pancreatic cancer. Pancreatology.
9:165–172. 2009. View Article : Google Scholar
|
14
|
Morales A, Morimoto S, Díaz L, Robles G
and Díaz-Sánchez V: Endocrine gland-derived vascular endothelial
growth factor in rat pancreas: genetic expression and testosterone
regulation. J Endocrinol. 197:309–314. 2008. View Article : Google Scholar : PubMed/NCBI
|
15
|
Dingli D, Chalub FA, Santos FC, Van
Segbroeck S and Pacheco JM: Cancer phenotype as the outcome of an
evolutionary game between normal and malignant cells. Br J Cancer.
101:1130–1136. 2009. View Article : Google Scholar : PubMed/NCBI
|
16
|
Stasinopoulos I, Mori N and Bhujwalla ZM:
The malignant phenotype of breast cancer cells is reduced by COX-2
silencing. Neoplasia. 10:1163–1169. 2008.PubMed/NCBI
|
17
|
Nielsen JD, Moeslund M, Wandall HH and
Dabelsteen S: Influences of tumor stroma on the malignant
phenotype. J Oral Pathol Med. 37:412–416. 2008. View Article : Google Scholar : PubMed/NCBI
|
18
|
Melnikova VO and Bar-Eli M:
Transcriptional control of the melanoma malignant phenotype. Cancer
Biol Ther. 7:997–1003. 2008. View Article : Google Scholar : PubMed/NCBI
|
19
|
Grzesiak JJ and Bouvet M: Divalent cations
modulate the integrin-mediated malignant phenotype in pancreatic
cancer cells. Cancer Sci. 99:1553–1563. 2008. View Article : Google Scholar : PubMed/NCBI
|
20
|
Ngan ES, Sit FY, Lee K, et al:
Implications of endocrine gland-derived vascular endothelial growth
factor/prokineticin-1 signaling in human neuroblastoma progression.
Clin Cancer Res. 13:868–875. 2007. View Article : Google Scholar : PubMed/NCBI
|
21
|
Koul HK, Pal M and Koul S: Role of p38 MAP
kinase signal transduction in solid tumors. Genes Cancer.
4:342–359. 2013. View Article : Google Scholar : PubMed/NCBI
|
22
|
Arlt A, Müerköster SS and Schäfer H:
Targeting apoptosis pathways in pancreatic cancer. Cancer Lett.
332:346–358. 2013. View Article : Google Scholar
|
23
|
Bayraktar S and Rocha-Lima CM: Advanced or
metastatic pancreatic cancer: molecular targeted therapies. Mt
Sinai J Med. 77:606–619. 2010. View Article : Google Scholar : PubMed/NCBI
|
24
|
Labasque M, Reiter E, Becamel C, et al:
Physical interaction of calmodulin with the 5-hydroxytryptamine2C
receptor C-terminus is essential for G protein-independent,
arrestin-dependent receptor signaling. Mol Biol Cell. 19:4640–4650.
2008. View Article : Google Scholar : PubMed/NCBI
|